Article in iScience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 6 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors at 4 institutions in 2 countries.
Kendi OkudaDivision of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, USA.
Miriam Maria Silva Costa FrancoDivision of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, USA.
Ari YasunagaDepartment of Microbiology, University of Pennsylvania, Philadelphia, PA, USA.
Ricardo GazzinelliDivision of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, USA.
Michel RabinovitchDepartment of Microbiology, Immunology and Parasitology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.
Sara CherryDepartment of Microbiology, University of Pennsylvania, Philadelphia, PA, USA.
Neal SilvermanDivision of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, USA.
University of Massachusetts Chan Medical School · USUniversity of Pennsylvania · USUniversidade Federal de Minas Gerais · BRUniversidade Federal de São Paulo · BR
Funding
Mechanisms of CD36-mediated parasitophorous vacuole maturation in macrophages infected with Leishmania amazonensisR21AI136532 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SILVERMAN, NEAL · 2018 to 2019
$461k
Leishmania amazonensis sabotages host SUMOylation: a novel virulence mechanism for macrophage invasionR21AI154208 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI OKUDA, KENDI, SILVERMAN, NEAL · 2020 to 2021
$461k
Host factors required for Leishmania infectionR21AI109678 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SILVERMAN, NEAL · 2014 to 2015
$460k
Elucidating Leishmania strategies for parasitophorous vacuole biogenesisR56AI165847 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SILVERMAN, NEAL · 2022 to 2022
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.